Target audience: 

Physicians
Allied Health Care Professionals

Learning objectives: 

  1. Review cardiovascular safety data for medications used to treat Type 2 diabetes

  2. Review specifically the role of SGLT2 inhibitors and GLP-1 agonists in management of Type 2 diabetes

  3. Review adverse effects reported with SGLT2 inhibitors and GLP-1 agonists

Faculty & credentials: 

Presenter:

Njeri Wainaina, MD
Associate Professor

Divisions of General Internal Medicine and Infectious Diseases

All persons in control of content have NO relevant financial relationships to disclose.

 

Michael Frank, MD

Activity Director

Contact

Name: 
Kathy A. Rafel
Phone number: 
+1 (414) 955-0531
Email: 
krafel@mcw.edu

ACCME Accreditation Statement:
The Medical College of Wisconsin is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

AMA Credit Designation Statement:
The Medical College of Wisconsin designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Hours of Participation for Allied Health Care Professionals:
The Medical College of Wisconsin designates this activity for up to 1.0 hours of participation for continuing education for allied health professionals.

Session date: 
01/25/2019 - 8:00am to 9:00am CST
Location: 
Froedtert Hospital
9200 W. Wisconsin Ave
Helfaer Auditorium
Milwaukee, WI 53226
United States
See map: Google Maps
Add to calendar: 
  • 1.00 AMA PRA Category 1 Credit(s)™
    AMA PRA Category 1 Credit(s)™
  • 1.00 Hours of Participation
    Hours of Participation credit.

Please login or register to take this course.